D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRR
1276
DELISTED
Carbo Ceramics Inc.
CRR
| $3.52M | ﹤0.01% |
1,005,748
+78,399
| +8% | +$274K |
|
1277
Natera
NTRA
$23.1B
| $3.51M | ﹤0.01% |
170,038
+55,086
| +48% | +$1.14M |
|
|
TOWR
1278
DELISTED
Tower International, Inc.
TOWR
| $3.51M | ﹤0.01% |
166,750
-61,428
| -27% | -$1.29M |
|
1279
CEVA Inc
CEVA
$564M
| $3.5M | ﹤0.01% |
129,859
+13,196
| +11% | +$356K |
|
|
DATA
1280
DELISTED
Tableau Software, Inc.
DATA
| $3.5M | ﹤0.01% |
27,460
+23,160
| +539% | +$2.95M |
|
1281
Surmodics
SRDX
$457M
| $3.49M | ﹤0.01% |
80,350
+1,136
| +1% | +$49.4K |
|
1282
Tenable Holdings
TENB
$3.62B
| $3.49M | ﹤0.01% |
+110,108
| New | +$3.49M |
|
|
TAST
1283
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $3.47M | ﹤0.01% |
348,461
+185,086
| +113% | +$1.85M |
|
|
EFII
1284
DELISTED
Electronics for Imaging
EFII
| $3.46M | ﹤0.01% |
128,557
+52,211
| +68% | +$1.4M |
|
|
ROIC
1285
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $3.44M | ﹤0.01% |
198,512
-236,321
| -54% | -$4.1M |
|
1286
Methanex
MEOH
$3.04B
| $3.44M | ﹤0.01% |
60,439
+6,945
| +13% | +$395K |
|
|
DSPG
1287
DELISTED
DSP Group Inc
DSPG
| $3.44M | ﹤0.01% |
244,215
+5,138
| +2% | +$72.3K |
|
1288
Idacorp
IDA
$6.77B
| $3.42M | ﹤0.01% |
34,400
-36,086
| -51% | -$3.59M |
|
|
ALTR
1289
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $3.41M | ﹤0.01% |
92,673
-15,172
| -14% | -$558K |
|
1290
Matrix Service
MTRX
$353M
| $3.41M | ﹤0.01% |
174,085
-39,390
| -18% | -$771K |
|
1291
Capitol Federal Financial
CFFN
$839M
| $3.4M | ﹤0.01% |
254,909
-116,143
| -31% | -$1.55M |
|
|
GPMT
1292
Granite Point Mortgage Trust
GPMT
$142M
| $3.38M | ﹤0.01% |
181,967
+37,021
| +26% | +$687K |
|
|
CVET
1293
DELISTED
Covetrus, Inc. Common Stock
CVET
| $3.37M | ﹤0.01% |
+105,857
| New | +$3.37M |
|
1294
Banco Santander Chile
BSAC
$12.1B
| $3.35M | ﹤0.01% |
112,709
+24,764
| +28% | +$737K |
|
1295
Diodes
DIOD
$2.44B
| $3.34M | ﹤0.01% |
96,338
-59,614
| -38% | -$2.07M |
|
1296
Lesaka Technologies
LSAK
$362M
| $3.34M | ﹤0.01% |
929,608
+299,161
| +47% | +$1.07M |
|
|
RDS.A
1297
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $3.32M | ﹤0.01% |
53,050
-454,109
| -90% | -$28.4M |
|
1298
Prologis
PLD
$107B
| $3.32M | ﹤0.01% |
46,091
-24,132
| -34% | -$1.74M |
|
1299
Caleres
CAL
$503M
| $3.31M | ﹤0.01% |
134,178
+124,466
| +1,282% | +$3.07M |
|
1300
Emergent Biosolutions
EBS
$434M
| $3.31M | ﹤0.01% |
65,472
-35,103
| -35% | -$1.77M |
|